INCYTE CORP Quarterly Cost of Revenue in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Incyte Corp quarterly/annual Cost of Revenue history and growth rate from Q1 2017 to Q3 2024.
  • Incyte Corp Cost of Revenue for the quarter ending September 30, 2024 was $86M, a 43.1% increase year-over-year.
  • Incyte Corp Cost of Revenue for the twelve months ending September 30, 2024 was $293M, a 20% increase year-over-year.
  • Incyte Corp annual Cost of Revenue for 2023 was $255M, a 23.2% increase from 2022.
  • Incyte Corp annual Cost of Revenue for 2022 was $207M, a 37.1% increase from 2021.
  • Incyte Corp annual Cost of Revenue for 2021 was $151M, a 15% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $293M $86M +$25.9M +43.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $267M $76.6M +$8.31M +12.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $259M $61M +$4.13M +7.28% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $255M $69.8M +$10.6M +17.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-13
Q3 2023 $244M $60.1M +$5.51M +10.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 $239M $68.3M +$17.7M +34.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $221M $56.8M +$14.2M +33.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $207M $59.2M +$15.3M +34.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-13
Q3 2022 $192M $54.6M +$14.7M +36.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $177M $50.6M +$12.6M +33.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $164M $42.6M +$13.4M +45.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $151M $43.9M +$7.55M +20.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-13
Q3 2021 $143M $39.9M +$5.55M +16.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $138M $38M +$4.66M +14% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $133M $29.2M +$1.9M +6.96% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $131M $36.3M +$4.11M +12.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-07
Q3 2020 $127M $34.3M +$4.28M +14.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $123M $33.4M +$3.96M +13.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $119M $27.3M +$4.73M +20.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $114M $32.2M +$5.85M +22.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-08
Q3 2019 $108M $30M +$5.25M +21.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $103M $29.4M +$4.55M +18.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $98.6M $22.6M +$4.48M +24.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $94.1M $26.4M +$4.01M +17.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-09
Q3 2018 $90.1M $24.8M +$2.76M +12.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $87.4M $24.9M +$4.6M +22.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 $82.8M $18.1M +$3.28M +22.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-30
Q4 2017 $79.5M $22.4M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-13
Q3 2017 $22M Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $20.3M Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $14.8M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.